IGA to raise funds and awareness to help parents and families end the nation’s opioid epidemic

CHICAGO, 2017-Aug-10 — /EPR Retail News/ — IGA USA today (August 8, 2017) announced that it is collaborating with Partnership for Drug-Free Kids to launch the first-ever IGA Cares initiative. Through in-store fundraising activities and the sales of specially marked IGA Exclusive Brand products, the IGA Cares initiative will support the mission of the Partnership, a national nonprofit dedicated to supporting families struggling with their son or daughter’s substance use. During this national campaign – which began running in participating IGA stores on August 1st – IGA will raise both critical funds and awareness to help parents and families and help end the nation’s opioid epidemic.

A number of in-store fundraising activites are available from August to December through the sale of specially marked IGA Exclusive Brand products available for purchase in participating IGA stores, and an instore pin-up promotion that will run in stores from mid-August through October. In addition to fundraising, IGA will help to raise awareness of the nation’s opioid epidemic and spread the word about how families can get help through the Partnership’s resources with an informational web page on www.igabetterchoices.com.

“For more than 90 years now, IGA retailers have been building the brand’s reputation by doing their part to give back and support worthy causes in the communities they serve,” Dave Bennett, IGA senior vice president of Procurement & Private Brands, said. “It is only natural that we would use the power of our IGA Exclusive Brand line to align IGA and its retailers with the causes that matter to today’s consumer on a national level, as well. Working with Partnership for Drug-Free Kids to raise awareness and funds during our first-ever IGA Cares initiative, we can do our part to make sure families in IGA communities across the country who are impacted by their son or daughter’s substance use don’t have to suffer alone.”

“With the launch of this inaugural IGA Cares initiative, IGA is demonstrating the true spirit of corporate social responsibility and solidifying their commitment to making a difference in the lives of so many families,” said Marcia Lee Taylor, Chief Policy Advisor for the Partnership for Drug-Free Kids. “We are honored that IGA has chosen to partner with us, especially at this critical time when the country is facing an urgent opioid epidemic. Through this effort, IGA will help us support parents and families who are dealing with a child’s substance use or addiction, and in doing so, they will undoubtedly help local IGA communities nationwide.”

Learn more about the Partnership’s extensive resources for families at drugfree.org. Learn more about IGA at www.iga.com.

About IGA
IGA is the world’s largest voluntary supermarket network with aggregate worldwide retail sales of more than $36 billion per year. The Alliance includes nearly 5,000 Hometown Proud Supermarkets worldwide, supported by 29 distribution centers and more than 30 major manufacturers, vendors and suppliers encompassing everything from grocery to equipment items and retail services. IGA has operations in 46 of the United States and more than 32 countries, commonwealths and territories.

About the Partnership for Drug-Free Kids
Partnership for Drug-Free Kids is committed to helping families struggling with their son or daughter’s substance use. We empower families with information, support and guidance to get the help their loved one needs and deserves. On our website, drugfree.org, and through our toll-free helpline (1-855-DRUGFREE), we provide families with direct support and guidance to help them address teen substance use. Finally, we build healthy communities, advocating for greater understanding and more effective programs to treat the disease of addiction. As a national nonprofit, we depend on donations from individuals, corporations, foundations and the public sector and are thankful to SAG-AFTRA and the advertising and media industries for their ongoing generosity. We are proud to receive a Four-Star rating from Charity Navigator, America’s largest and most-utilized independent evaluator of charities, as well as a National Accredited Charity Seal from the Better Business Bureau’s Wise Giving Alliance.

Contact:

Phone: (773) 693-4520
Fax: (773) 693-4533

Source: IGA

Naloxone opioid overdose-reversal drug now available without prescription at all CVS Pharmacy locations in Nevada

WOONSOCKET, R.I., , 2016-Dec-19 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (December 14, 2016) that the opioid overdose-reversal medication naloxone is now available without a prescription at all CVS Pharmacy locations in Nevada. CVS Health has established a standing order with physicians in Nevada that allows CVS Pharmacy to expand access to the medication across the state.

“Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our Nevada pharmacies by the use of a physician’s standing order for patients without a prescription, we can help save lives,” said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. “We are dedicated to helping the communities we serve address and prevent drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery.”

The move to expand access to naloxone builds on CVS Health’s longstanding commitment to help communities address and prevent drug abuse through education, outreach and safe medication disposal. CVS Health’s commitment to drug abuse prevention education extends from online resources for patients visiting CVS.com to a commitment to youth prevention programs. Launched in 2015, CVS Health’s Pharmacists Teach program gives its pharmacists the opportunity to volunteer to speak to local students about the dangers of drug abuse. More than 150,000 students have already been part of the program. The CVS Health Foundation is also working with DoSomething.org to create a peer-to-peer prevention and intervention program delivered to young people via text message and online.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which has donated more than 600 drug disposal units to police departments around the country. The program gives members of the community a safe and environmentally friendly way to dispose of unwanted medication and has already collected more than 47 metric tons of prescription drugs.

“CVS Health has been a leader in the work of helping communities prevent prescription drug abuse,” said Marcia Lee Taylor, President and CEO, Partnership for Drug-Free Kids. “In addition to proper disposal of unwanted medication, increasing access to naloxone is a critical public health priority that allows patients and their families to prevent opioid fatalities and recognize when people need help working towards recovery from the disease of addiction.”

With the addition of Nevada, CVS Pharmacy now dispenses naloxone in a total of 37 states: Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Florida, Idaho, Illinois, Indiana, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at www.cvshealth.com.

Media Contact:

Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

SOURCE: CVS Health

Opioid overdose-reversal drug naloxone now available in CVS pharmacies in Alabama, Alaska, Illinois, Missouri and West Virginia

WOONSOCKET, R.I., 2016-Oct-03 — /EPR Retail News/ — CVS Health (NYSE: CVS) today (September 29, 2016) announced it has expanded access to the opioid overdose-reversal drug naloxone in Alabama, Alaska, Illinois, Missouri and West Virginia, allowing CVS Pharmacy patients to access the medication without an individual prescription. In total, CVS Pharmacy patients in 36 states now have increased access to the life-saving opioid overdose-reversal drug. CVS Health’s naloxone program establishes a standing order with a physician in the state or utilizes pharmacists’ prescriptive authority to permit CVS Pharmacists to dispense naloxone to patients without an individual prescription. Pharmacists in these five states began dispensing the medication this week.

“Naloxone is a safe and effective antidote to opioid overdose and by expanding availability of this medication, we can save lives and give more people a chance to get the help they need for recovery,” said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. “By establishing a physician-authorized standing order that allows our pharmacies to dispense naloxone to patients without an individual prescription, we strengthen our commitment to helping the communities we serve begin to address the challenges of prescription drug abuse.”

“Expanding access to the overdose-reversal drug naloxone is a critical part of our national strategy to stop the prescription drug and heroin overdose epidemic along with effective prevention, treatment, and enforcement,” said Michael Botticelli, Director of National Drug Control Policy. “Thanks to efforts on naloxone like those announced today by CVS Health, more Americans will have access to this lifesaving drug.”

The move to expand access to naloxone builds on CVS Health’s longstanding commitment to help communities address and prevent drug abuse through education, outreach and safe medication disposal. CVS Health’s commitment to drug abuse prevention education extends from online resources launched for patients visiting CVS.com to two robust youth prevention programs. Launched last year, CVS Health’s Pharmacists Teach program gives its pharmacists the opportunity to volunteer to speak to high school health classes about the dangers of drug abuse. More than 100,000 students have already been part of the program. Recently, the company also announced a partnership with DoSomething.org to create a peer-to-peer prevention and intervention program delivered to young people via text message and online.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which has donated more than 600 drug disposal units to police departments around the country. The program gives members of the community a safe and environmentally friendly way to dispose of unwanted medication and has already collected more than 47 metric tons of prescription drugs.

“CVS Health has been a leader in the work of helping communities prevent prescription drug abuse,” said Marcia Lee Taylor, President and CEO, Partnership for Drug-Free Kids. “In addition to proper disposal of unwanted medication, increasing access to naloxone is a critical public health priority that allows patients and their families to prevent opioid fatalities and recognize when people need help working towards recovery from the disease of addiction.”

With the addition of the five new states where CVS Pharmacy locations began dispensing naloxone to patients without a prescription this week, CVS Pharmacy locations in the following 36 states now offer naloxone: Alabama, Alaska, Arkansas,California, Colorado, Connecticut, Florida, Idaho, Illinois, Indiana, Kentucky,Louisiana, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana,New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota,Ohio, Oregon, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, Vermont,Virginia, Washington, West Virginia and Wisconsin. CVS Health also plans to further expand its naloxone program to other states in the coming months.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:
Erin Shields Britt
Corporate Communications
401-770-9237
Erin.Britt@CVSHealth.com

SOURCE: CVS Health

CVS Health expands access to opioid overdose-reversal drug naloxone in seven additional states this summer

WOONSOCKET, R.I., 2016-May-25 — /EPR Retail News/ — CVS Health (NYSE: CVS) today announced it will expand access to the opioid overdose-reversal drug naloxone in seven additional states this summer, contributing to a total of 30 states where the life-saving medication will be more accessible to CVS Pharmacy patients. CVS Health’s naloxone program establishes a standing order with a physician in the state, which permits CVS Pharmacists to dispense naloxone to patients without an individual prescription.

“Naloxone is a safe and effective antidote to opioid overdose and by expanding availability of this medication, we can save lives and give more people a chance to get the help they need for recovery,” said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. “By establishing a physician-authorized standing order that allows our pharmacies to dispense naloxone to patients without an individual prescription, we strengthen our commitment to helping the communities we serve begin to address the challenges of prescription drug abuse.”

Expansion of the company’s naloxone program will begin with New Mexico in late May; followed by Louisiana in early June; Florida in early July; Colorado, Idaho andOregon in mid-July; and Washington in early August. Naloxone is already available without a prescription at CVS Pharmacy locations through standing order or collaborative practice agreements in 23 states: Arkansas, California, Connecticut,Indiana, Kentucky, Maryland, Massachusetts, Minnesota, Mississippi, Montana, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio,Pennsylvania, Rhode Island, Tennessee, Utah, Vermont, Virginia and Wisconsin.

“Expanding access to the overdose-reversal drug naloxone is a critical part of our national strategy to stop the prescription drug and heroin overdose epidemic along with effective prevention, treatment, and enforcement,” said Michael Botticelli, Director of National Drug Control Policy. “Thanks to efforts on naloxone like those announced today by CVS Health, more Americans will have access to this lifesaving drug.”

The move to expand access to naloxone builds on CVS Health’s longstanding commitment to help communities address and prevent drug abuse through education, outreach and safe medication disposal. Patients visiting CVS.com can find recently launched drug abuse prevention resources for themselves and their families. The company has also launched a community outreach program called Pharmacists Teach, which brings local pharmacists to high school health classes to talk to students about the dangers of drug abuse. More than 80,000 students have already been part of the program. High schools across the country can learn more about bringing Pharmacists Teach to their school here.

CVS Health has also joined with the Partnership for Drug-Free Kids for the Medication Disposal for Safer Communities Program, which has donated more than 500 drug disposal units to police departments around the country. The program gives members of the community a safe and environmentally friendly way to dispose of unwanted medication and has already collected more than 35 metric tons of prescription drugs. Police departments across the country can apply to receive a drug collection unit from the program here.

“CVS Health has been a leader in the work of helping communities prevent prescription drug abuse,” said Marcia Lee Taylor, President and CEO, Partnership for Drug-Free Kids. “In addition to proper disposal of unwanted medication, increasing access to naloxone is a critical public health priority that allows patients and their families to prevent opioid fatalities and recognize when people need help working towards recovery from the disease of addiction.”

About CVS Health:
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:
Erin Shields Britt
Corporate Communications
401-770-9237
Erin.Britt@CVSHealth.com

SOURCE CVS Health